Area of research
Developmental Neuroscience · Cancer Research
Research interest
Research interests include Neurogenesis and neuroplasticity mechanisms, MicroRNA in disease regulation, Spine and Intervertebral Disc Pathology, and Diabetes Treatment and Management.
Plasma Exosomal LncRNA XIST Impairs CD4<sup>+</sup> T Cell Autophagy and Promotes Activation via the miR-98/RICTOR/Akt-mTOR Axis in Systemic Lupus Erythematosus.
Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes
Lithium Nitrate-Mediated Low-Volatile Deep Eutectic Electrolyte for Highly Stable Lithium–Oxygen Batteries
The relationship between oxidative balance score and circadian syndrome: evidence from the NHANES 2005-2018
N6-methyladenosine hypomethylation of circGPATCH2L regulates DNA damage and apoptosis through TRIM28 in intervertebral disc degeneration
Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
The Role of Extracellular Vesicles in Systemic Lupus Erythematosus
Why the patients with Hirayama disease have abnormal cervical sagittal alignment? A radiological measurement analysis of posterior cervical extensors
The Role of Extracellular Vesicles in Systemic Lupus Erythematosus.
Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer
A Novel Long Noncoding RNA lincRNA00892 Activates CD4<sup>+</sup> T Cells in Systemic Lupus Erythematosus by Regulating CD40L.
Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas
MSC-Derived Exosomes Protect Vertebral Endplate Chondrocytes against Apoptosis and Calcification via the miR-31-5p/ATF6 Axis
CircERCC2 ameliorated intervertebral disc degeneration by regulating mitophagy and apoptosis through miR-182-5p/SIRT1 axis
Molecular Detection and Assessment of Intervertebral Disc Degeneration via a Collagen Hybridizing Peptide
Interaction between IL-33 Gene Polymorphisms and Current Smoking with Susceptibility to Systemic Lupus Erythematosus.
Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4<sup>+</sup> T cells.
Azithromycin promotes alternatively activated macrophage phenotype in systematic lupus erythematosus via PI3K/Akt signaling pathway
Cerebral ischemia induces angiogenesis in the peri-infarct regions via Notch1 signaling activation
Cancer therapy in the necroptosis era
miR‐200c/Bmi1 axis and epithelial–mesenchymal transition contribute to acquired resistance to <scp>BRAF</scp> inhibitor treatment